康恩贝：盐酸丙卡特罗吸入溶液获得药品注册证书

Core Viewpoint - Kang En Bei (600572) announced the approval of two specifications of hydrochloride pirbuterol inhalation solution by the National Medical Products Administration, which is primarily used to relieve symptoms of bronchial asthma, chronic bronchitis, and emphysema based on airflow limitation [1] Group 1 - The product received a drug registration certificate from the National Medical Products Administration [1] - The inhalation solution is intended for the treatment of respiratory diseases [1]